Springer Nature
Browse
12883_2016_635_MOESM1_ESM.docx (20.67 kB)

Additional file 1: Table S1. of Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study

Download (20.67 kB)
journal contribution
posted on 2016-07-26, 05:00 authored by Ralf Gold, Ernst-Wilhelm Radue, Gavin Giovannoni, Krzysztof Selmaj, Eva Havrdova, Dusan Stefoski, Till Sprenger, Xavier Montalban, Stanley Cohan, Kimberly Umans, Steven Greenberg, Gulden Ozen, Jacob Elkins
List of IECs and/or IRBs for SELECTED. (DOCX 20 kb)

Funding

Biogen

History

Usage metrics

    BMC Neurology

    Categories

    Keywords

    Relapsing-remitting multiple sclerosisDaclizumabSafetyEfficacy

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC